Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Blaize Holdings, Inc.BZAI · Entity 7049 | Director | December 03, 2025 | December 05, 2025 |
| HeartBeam, Inc.BEAT · Entity 9039 | Director | October 02, 2026 | October 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Blaize Holdings, Inc.
Report date December 03, 2025 · Filed December 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 169,619 |
Reported balance
After 2025-12-03 transaction · row 1
1 source rowRow 1 · 2025-12-03 · Grant · Acquired 75,258 · Balance 169,619 F1: Represents an award of restricted stock units granted at the Issuer's 2025 Annual Meeting under the Non-Employee Director Compensation Program, which vest at the ealier of one year or the Issuer's next Annual Meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units granted at the Issuer's 2025 Annual Meeting under the Non-Employee Director Compensation Program, which vest at the ealier of one year or the Issuer's next Annual Meeting.
HeartBeam, Inc.
Report date October 02, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 93,750 |
Reported balance
After 2026-10-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-02 · Grant · Acquired 93,750 · Balance 93,750 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement. F2: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.44 · Expires 2036-10-02 | Direct | 93,750 |
Reported balance
After 2026-10-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-02 · Grant · Acquired 93,750 · Balance 93,750 F3: The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan). |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement.
F2: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.
F3: The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 9, 2026 20:21 UTC | HeartBeam, Inc. BEAT · Entity 9039 | GrantStock Option (Right to Buy) · Derivative | 93,750 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001213900-26-108486 · ownership.xml · derivative · entry 2 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 93,750 shares Expires 2036-10-02 F3 · derivative.exercise_date: The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan). Read SEC document |
| October 02, 2026 Filed Oct 9, 2026 20:21 UTC | HeartBeam, Inc. BEAT · Entity 9039 | GrantRestricted Stock Units · Derivative | 93,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-108486 · ownership.xml · derivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 93,750 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement. F2 · derivative.exercise_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. F2 · derivative.expiration_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. Read SEC document |
| February 09, 2026 Filed Mar 23, 2026 17:31 UTC | HeartBeam, Inc. BEAT · Entity 9039 | GrantCommon Stock (right to buy) · Derivative | 51,724 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001213900-26-033025 · ownership.xml · derivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,724 Underlying: Common Stock · 51,724 shares Expires 2036-01-01 F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 17:10 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 33,185 | $2.83 | $93,913.55 |
DisclosureSEC source: 0001213900-25-123939 · ownership.xml · nonDerivative · entry 2 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 17:10 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 23,961 | $3.68 | $88,176.48 |
DisclosureSEC source: 0001213900-25-123939 · ownership.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,185 F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. F2 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 21:04 UTC | Blaize Holdings, Inc. BZAI · Entity 7049 | GrantCommon Stock | 75,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-055584 · wk-form4_1764968678.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,619 F1 · shares: Represents an award of restricted stock units granted at the Issuer's 2025 Annual Meeting under the Non-Employee Director Compensation Program, which vest at the ealier of one year or the Issuer's next Annual Meeting. Read SEC document |
| June 28, 2025 Filed Jul 2, 2025 23:08 UTC | Blaize Holdings, Inc. BZAI · Entity 7049 | GrantCommon Stock | 94,361 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-093372 · ownership.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,361 F1 · kind: Represents an award of restricted stock units which vest in accordance with the applicable grant agreement. Read SEC document |
| September 06, 2024 Filed Sep 11, 2024 16:36 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 1,674 | $2.34 | $3,917.16 |
DisclosureSEC source: 0001628280-24-040139 · wk-form4_1726086999.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,146 F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 18:25 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 5,500 | $2.31 | $12,705.00 |
DisclosureSEC source: 0001628280-24-039383 · wk-form4_1725485085.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,820 F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024. Read SEC document |
| August 27, 2024 Filed Aug 29, 2024 16:18 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 2,194 | $2.26 | $4,958.44 |
DisclosureSEC source: 0001628280-24-038817 · wk-form4_1724962716.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,320 F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024. Read SEC document |
| August 26, 2024 Filed Aug 27, 2024 15:07 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 300 | $2.38 | $714.00 |
DisclosureSEC source: 0001628280-24-038522 · wk-form4_1724785648.xml · nonDerivative · entry 2 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,514 F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024. Read SEC document |
| August 23, 2024 Filed Aug 27, 2024 15:07 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 2,500 | $2.30 | $5,750.00 |
DisclosureSEC source: 0001628280-24-038522 · wk-form4_1724785648.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,814 F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024. Read SEC document |
| June 12, 2024 Filed Jun 20, 2024 15:27 UTC | HeartBeam, Inc. BEAT · Entity 9039 | GrantCommon Stock | 33,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-24-000011 · wk-form4_1718911653.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,314 F1 · ownership.direct: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of June 12, 2025, or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 19:18 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 5,500 | $2.06 | $11,330.00 |
DisclosureSEC source: 0001779372-23-000033 · wk-form4_1696375072.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,129 F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares. Read SEC document |
| September 28, 2023 Filed Sep 29, 2023 19:41 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 8,000 | $2.04 | $16,320.00 |
DisclosureSEC source: 0001779372-23-000031 · wk-form4_1696030856.xml · nonDerivative · entry 2 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,629 F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares. Read SEC document |
| September 27, 2023 Filed Sep 29, 2023 19:41 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 1,834 | $2.11 | $3,869.74 |
DisclosureSEC source: 0001779372-23-000031 · wk-form4_1696030856.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,629 F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares. Read SEC document |
| September 26, 2023 Filed Sep 27, 2023 12:01 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 5,000 | $2.09 | $10,450.00 |
DisclosureSEC source: 0001779372-23-000029 · wk-form4_1695830472.xml · nonDerivative · entry 2 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,463 F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares. Read SEC document |
| September 22, 2023 Filed Sep 27, 2023 12:01 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 2,393 | $2.21 | $5,288.53 |
DisclosureSEC source: 0001779372-23-000029 · wk-form4_1695830472.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,463 F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares. Read SEC document |
| September 21, 2023 Filed Sep 22, 2023 19:07 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 100 | $2.41 | $241.00 |
DisclosureSEC source: 0001779372-23-000027 · wk-form4_1695424023.xml · nonDerivative · entry 2 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,856 F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares. Read SEC document |
| September 20, 2023 Filed Sep 22, 2023 19:07 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 883 | $2.46 | $2,172.18 |
DisclosureSEC source: 0001779372-23-000027 · wk-form4_1695424023.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,956 F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares. Read SEC document |
| September 18, 2023 Filed Sep 19, 2023 18:51 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 5,000 | $2.46 | $12,300.00 |
DisclosureSEC source: 0001779372-23-000024 · wk-form4_1695163870.xml · nonDerivative · entry 2 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,839 F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 18:51 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 4,269 | $2.43 | $10,373.67 |
DisclosureSEC source: 0001779372-23-000024 · wk-form4_1695163870.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,839 F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 17:36 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 5,000 | $2.17 | $10,850.00 |
DisclosureSEC source: 0001779372-23-000022 · wk-form4_1694813790.xml · nonDerivative · entry 3 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,108 F1 · shares: 1. These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares. Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 17:36 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 3,122 | $1.95 | $6,087.90 |
DisclosureSEC source: 0001779372-23-000022 · wk-form4_1694813790.xml · nonDerivative · entry 2 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,108 F1 · shares: 1. These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares. Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 17:36 UTC | HeartBeam, Inc. BEAT · Entity 9039 | SaleCommon Stock | 1,878 | $1.90 | $3,568.20 |
DisclosureSEC source: 0001779372-23-000022 · wk-form4_1694813790.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,230 F1 · shares: 1. These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:58 UTC | HeartBeam, Inc. BEAT · Entity 9039 | GrantCommon Stock | 23,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-057564 · ownership.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,108 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 13, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 21:33 UTC | HeartBeam, Inc. BEAT · Entity 9039 | GrantCommon Stock | 55,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000031 · wf-form4_165828076227389.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,147 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 15, 2023 or the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date. Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 21:57 UTC | HeartBeam, Inc. BEAT · Entity 9039 | GrantCommon Stock Option (right to buy) · Derivative | 44,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001213900-21-059710 · ownership.xml · derivative · entry 1 DE URIOSTE GEORGE · CIK 0001270068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2031-07-25 F1 · derivative.exercise_date: The option will vest one forty-eighth of the shares on each one-month anniversary of the vesting commencement date such that 100% of the shares subject to the option will be fully vested and exercisable on August 27, 2025. F2 · derivative.exercise_date: All shares subject to the option shall accelerate and vest in full upon the Company's termination of the optionee's engagement with the Company following a Change in Control (as defined in the agreement). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.